Literature DB >> 21920554

Toll-like receptor 4 mediates oxidized LDL-induced macrophage differentiation to foam cells.

Kenneth W Howell1, Xianzhong Meng, David A Fullerton, Chunhua Jin, T Brett Reece, Joseph C Cleveland.   

Abstract

BACKGROUND: Macrophage foam cells are central in the development of atherosclerosis, but the mechanism of foam cell formation is unclear. Toll-like receptor 4 (TLR4) signaling is known to participate in the pathogenesis of atherosclerosis. Further, oxidized low density lipoprotein (oxLDL) enhances TLR4 expression in macrophages. We hypothesized that TLR4 mediates macrophage differentiation to foam cells.
METHODS: Peritoneal macrophages were isolated by lavage from TLR4 competent C3H/HeN mice and TLR4 defective C3H/HeJ mice. Cells were treated with oxLDL, lipopolysaccharide (LPS), or oxLDL plus LPS. Cells were also treated with a TLR4 blocking antibody before oxLDL treatment. Foam cells were identified by Oil red O staining for intracellular lipids. Percent macrophage differentiation into foam cells were compared between C3H/HeN and C3H/HeJ macrophages.
RESULTS: Following oxLDL treatment 29% of TLR4 competent macrophages differentiated into foam cells compared to 5.8% of TLR4 defective macrophages (P < 0.01). Pretreatment with a TLR4 blocking antibody decreased the differentiation of TLR4 competent cells to foam cells from 29% to 13% (P < 0.01). Stimulation of TLR4 with LPS in the presence of oxLDL increased differentiation of TLR4 competent cells to foam cells from 29% to 60% (P < 0.01). In addition, there was a pattern in the spatial relationship between foam cells that were consistently observed in clusters rather than as isolated cells.
CONCLUSIONS: TLR4 is necessary for oxLDL-induced macrophage differentiation to foam cells. Macrophage foam cell clustering may indicate an underlying intercellular signaling mechanism that facilitates foam cell formation. We conclude that TLR4 contributes to the pathogenesis of atherosclerosis by promoting foam cell formation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21920554     DOI: 10.1016/j.jss.2011.06.033

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  31 in total

Review 1.  Cardiovascular complications in inflammatory bowel disease.

Authors:  Rudolf Schicho; Gunther Marsche; Martin Storr
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  CD14 is a key mediator of both lysophosphatidic acid and lipopolysaccharide induction of foam cell formation.

Authors:  Dong An; Feng Hao; Fuqiang Zhang; Wei Kong; Jerold Chun; Xuemin Xu; Mei-Zhen Cui
Journal:  J Biol Chem       Date:  2017-07-13       Impact factor: 5.157

Review 3.  Inflammation-induced foam cell formation in chronic inflammatory disease.

Authors:  Thomas A Angelovich; Anna C Hearps; Anthony Jaworowski
Journal:  Immunol Cell Biol       Date:  2015-03-10       Impact factor: 5.126

4.  Cathepsin B regulates hepatic lipid metabolism by cleaving liver fatty acid-binding protein.

Authors:  Simeon Thibeaux; Shaila Siddiqi; Olga Zhelyabovska; Faisal Moinuddin; Michal M Masternak; Shadab A Siddiqi
Journal:  J Biol Chem       Date:  2017-12-19       Impact factor: 5.157

Review 5.  Impact of Immune System Activation and Vascular Impairment on Male and Female Sexual Dysfunction.

Authors:  Fabiano B Calmasini; Nicole Klee; R Clinton Webb; Fernanda Priviero
Journal:  Sex Med Rev       Date:  2019-07-17

Review 6.  Growth Factors as Immunotherapeutic Targets in Cardiovascular Disease.

Authors:  John E Mindur; Filip K Swirski
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-05-16       Impact factor: 8.311

Review 7.  Toll-like receptor 4 mediates vascular remodeling in hyperhomocysteinemia.

Authors:  Anastasia Familtseva; Nevena Jeremic; George H Kunkel; Suresh C Tyagi
Journal:  Mol Cell Biochem       Date:  2017-04-06       Impact factor: 3.396

8.  Tenascin-C produced by oxidized LDL-stimulated macrophages increases foam cell formation through Toll-like receptor-4.

Authors:  Rui Liu; Yong He; Bo Li; Jun Liu; Yingang Ren; Wei Han; Xing Wang; Lihua Zhang
Journal:  Mol Cells       Date:  2012-06-12       Impact factor: 5.034

9.  Cyclooxygenase 2, toll-like receptor 4 and interleukin 1β mRNA expression in atherosclerotic plaques of type 2 diabetic patients.

Authors:  Alessandro Baldan; Silvia Ferronato; Silvia Olivato; Giovanni Malerba; Alberto Scuro; Gian Franco Veraldi; Matteo Gelati; Sergio Ferrari; Sara Mariotto; Pier Franco Pignatti; Sara Mazzucco; Macarena Gomez-Lira
Journal:  Inflamm Res       Date:  2014-08-06       Impact factor: 4.575

10.  The disintegrin, trimucrin, suppresses LPS-induced activation of phagocytes primarily through blockade of NF-κB and MAPK activation.

Authors:  Yu-Chun Hung; Chun-Chieh Hsu; Ching-Hu Chung; Tur-Fu Huang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-31       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.